And why two analysts say this e-commerce company is the one to buy right now.
Read MoreThese 4 stocks have been surging so far this year and are likely to continue to head higher.
Read MoreCan-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company’s lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical […]
Read MoreThroughout this week, one of the biggest news stories, without question, has been the fatal crash of a Boeing 737 MAX jet flown by Ethiopian Air shortly after takeoff on March 10. The crash took the lives of all 157 that were onboard the plane, and it was the second such crash in five months […]
Read MoreThe old adage “buy the rumor, sell the news” came to the forefront of the markets when Take-Two Interactive Software Inc. (TTWO) became one of the top-performing S&P 500 stocks on Wednesday. Investors poured into the publisher of hit video-game series like “Grand Theft Auto” and “NBA 2K” on buyout rumors, which are now considered […]
Read More